MedTrace Logo

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

NCT01956786 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2013-10-08

No results posted yet for this study

Summary

To evaluate the efficacy of Amlodipine-Folic Acid Tablets on reduction of blood pressure and plasma total homocysteine.

Conditions

  • Essential Hypertension

Interventions

DRUG

Amlodipine-FA tablet,low dose group

5mg amlodipine combined with 0.4mg folic acid,once daily (Low-dose group)

DRUG

Amlodipine-FA tablet,high dose group

5mg amlodipine combined with 0.8mg folic acid,once daily (High-dose group)

DRUG

Amlodipine

5mg amlodipine,once daily

Sponsors & Collaborators

  • Ruijin Hospital

    collaborator OTHER

  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER

  • Xuzhou Medical University

    collaborator OTHER

  • Shenzhen Ausa Pharmed Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Wang Jiguang, MD · Ruijin Hospital, Shanghai Jiao Tong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2013-12-31
Completion
2014-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01956786 on ClinicalTrials.gov